High Fiber Rye Foods for Body Weight and Body Fat Reduction
RyeWeight2
1 other identifier
interventional
255
1 country
1
Brief Summary
The overall aim of this study is to investigate whether a diet rich in rye fiber from wholegrain rye, compared to refined wheat, as part of a hypo-caloric diet leads to larger weight loss and lower body fat content after 12 weeks of intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable obesity
Started Jan 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 13, 2019
CompletedFirst Posted
Study publicly available on registry
December 18, 2019
CompletedStudy Start
First participant enrolled
January 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 8, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 8, 2021
CompletedJuly 19, 2021
July 1, 2021
1.4 years
December 13, 2019
July 16, 2021
Conditions
Outcome Measures
Primary Outcomes (2)
Investigate if there is a difference in body weight at week 12
Measured on a scale
12 weeks
Investigate if there is a difference in body fat mass at week 12
Measured by dual energy x-ray absorptiometry
12 weeks
Secondary Outcomes (16)
Investigate if there are differences in subjective appetite ratings
0 weeks, 6 weeks and 12 weeks.
Investigate if differences in primary endpoints (body weight) are apparent at week 6
6 weeks
Investigate if differences in primary endpoints (fat mass) are apparent at week 6
6 weeks
Investigate if lean body mass differs between intervention groups after 6 and 12 weeks of intervention
6 weeks and 12 weeks
Investigate if abdominal fat mass differs between intervention groups after 6 and 12 weeks of intervention
6 weeks and 12 weeks
- +11 more secondary outcomes
Study Arms (2)
Wholegrain rye products with a high content of dietary fiber
EXPERIMENTALCereal products based on wholegrain rye
Refined wheat products with a low content of dietary fiber
ACTIVE COMPARATORCereal products based on refined wheat
Interventions
Participants will receive a fixed amount of rye based cereals products, corresponding to approx 650 kcal/day.
Participants will receive a fixed amount of wheat based cereals products, corresponding to approx 650 kcal/day.
Eligibility Criteria
You may qualify if:
- Men and women
- Age 30-70 y
- BMI 27-35 kg/m2
- Hemoglobin ≥117g/l for women and for men ≥134g/l
- Thyroid stimulating hormone (TSH) ≤4.30 mIU/L
- Low density lipoprotein (LDL) cholesterol ≤5.30 mmol/L
- Triglycerides ≤2.60 mmol/L
- Signed informed consent
You may not qualify if:
- Blood donation or participation in a clinical study with blood sampling within 30 days prior to screening visit and throughout the study
- Unable to satisfactorily complete the 3-day weighted food record between screening visits.
- Unable to lose ≥0.5 kg during the run-in period for men and women not having menstruation during the run-in period
- Increased body weight, despite reported adherence to dietary intake for women with menstruation during the run-in period.
- Using nicotine products on a daily basis (incl. chewing gum, patches, snus etc.)
- Using e-cigarettes (regardless of nicotine content)
- Following any weight reduction program or having followed one during the last 6 months prior to visit 1.
- Diastolic blood pressure 105 mmHg or more at visit 1
- Systolic blood pressure 160 mmHg or more at visit 1
- History of stomach or gastrointestinal conditions (Inflammatory bowel disease, Crohn's disease, malabsorption, colostomy, bowel resection, gastric bypass surgery etc.)
- More than 10 hours physical activity per week
- History of heart failure or heart attack within 1 year prior to screening
- Having type I diabetes
- Receiving pharmacological treatment for type II diabetes (treatments based on life style interventions are acceptable, as long as they are compatible with the study protocol)
- Previous gastrointestinal surgery, with the exception of minor surgeries such removal of appendix or gall bladder at least 6 months prior to screening.
- +10 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chalmers University of Technology
Gothenburg, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rikard Landberg, PhD
Chalmers University of Technology
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
December 13, 2019
First Posted
December 18, 2019
Study Start
January 20, 2020
Primary Completion
June 8, 2021
Study Completion
June 8, 2021
Last Updated
July 19, 2021
Record last verified: 2021-07
Data Sharing
- IPD Sharing
- Will not share